PortfoliosLab logo
PortfoliosLab logo
Tools
Portfolios
Screeners
Discussions
TEVA vs. KVUE
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

TEVA vs. KVUE

Last updated May 11, 2025

Compare and contrast key facts about Teva Pharmaceutical Industries Limited (TEVA) and Kenvue Inc. (KVUE).

Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: TEVA or KVUE.

Correlation

The correlation between TEVA and KVUE is 0.20, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

TEVA vs. KVUE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Teva Pharmaceutical Industries Limited (TEVA) and Kenvue Inc. (KVUE). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

TEVA:

0.12

KVUE:

0.82

Sortino Ratio

TEVA:

1.09

KVUE:

1.64

Omega Ratio

TEVA:

1.14

KVUE:

1.20

Calmar Ratio

TEVA:

0.26

KVUE:

0.76

Martin Ratio

TEVA:

1.24

KVUE:

3.33

Ulcer Index

TEVA:

17.21%

KVUE:

7.58%

Daily Std Dev

TEVA:

47.40%

KVUE:

27.55%

Max Drawdown

TEVA:

-90.80%

KVUE:

-33.22%

Current Drawdown

TEVA:

-74.73%

KVUE:

-4.88%

Fundamentals

Market Cap

TEVA:

$19.42B

KVUE:

$46.92B

EPS

TEVA:

-$1.15

KVUE:

$0.56

PEG Ratio

TEVA:

1.29

KVUE:

2.50

PS Ratio

TEVA:

1.25

KVUE:

3.03

PB Ratio

TEVA:

3.31

KVUE:

4.67

Total Revenue (TTM)

TEVA:

$16.61B

KVUE:

$11.56B

Gross Profit (TTM)

TEVA:

$8.17B

KVUE:

$6.71B

EBITDA (TTM)

TEVA:

$725.00M

KVUE:

$2.36B

Returns By Period

In the year-to-date period, TEVA achieves a -23.19% return, which is significantly lower than KVUE's 15.61% return.

TEVA

YTD

-23.19%

1M

32.06%

6M

-1.05%

1Y

4.18%

5Y*

8.16%

10Y*

-11.39%

KVUE

YTD

15.61%

1M

11.75%

6M

5.14%

1Y

22.39%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Risk-Adjusted Performance

TEVA vs. KVUE — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
TEVA
The Risk-Adjusted Performance Rank of TEVA is 6565
Overall Rank
The Sharpe Ratio Rank of TEVA is 5858
Sharpe Ratio Rank
The Sortino Ratio Rank of TEVA is 6868
Sortino Ratio Rank
The Omega Ratio Rank of TEVA is 6666
Omega Ratio Rank
The Calmar Ratio Rank of TEVA is 6464
Calmar Ratio Rank
The Martin Ratio Rank of TEVA is 6767
Martin Ratio Rank
KVUE
The Risk-Adjusted Performance Rank of KVUE is 7979
Overall Rank
The Sharpe Ratio Rank of KVUE is 8080
Sharpe Ratio Rank
The Sortino Ratio Rank of KVUE is 8080
Sortino Ratio Rank
The Omega Ratio Rank of KVUE is 7676
Omega Ratio Rank
The Calmar Ratio Rank of KVUE is 8080
Calmar Ratio Rank
The Martin Ratio Rank of KVUE is 8181
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

TEVA vs. KVUE - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Teva Pharmaceutical Industries Limited (TEVA) and Kenvue Inc. (KVUE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current TEVA Sharpe Ratio is 0.12, which is lower than the KVUE Sharpe Ratio of 0.82. The chart below compares the historical Sharpe Ratios of TEVA and KVUE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Loading data...

Dividends

TEVA vs. KVUE - Dividend Comparison

TEVA has not paid dividends to shareholders, while KVUE's dividend yield for the trailing twelve months is around 2.52%.

TTM20242023202220212020201920182017201620152014
TEVA
Teva Pharmaceutical Industries Limited		0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%4.49%3.75%2.07%2.38%
KVUE
Kenvue Inc.		2.52%3.79%1.86%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

TEVA vs. KVUE - Drawdown Comparison

The maximum TEVA drawdown since its inception was -90.80%, which is greater than KVUE's maximum drawdown of -33.22%. Use the drawdown chart below to compare losses from any high point for TEVA and KVUE. For additional features, visit the drawdowns tool.

Loading data...

Volatility

TEVA vs. KVUE - Volatility Comparison

Teva Pharmaceutical Industries Limited (TEVA) has a higher volatility of 18.25% compared to Kenvue Inc. (KVUE) at 9.45%. This indicates that TEVA's price experiences larger fluctuations and is considered to be riskier than KVUE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Loading data...

Financials

TEVA vs. KVUE - Financials Comparison

This section allows you to compare key financial metrics between Teva Pharmaceutical Industries Limited and Kenvue Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.

Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities

3.60B3.80B4.00B4.20B4.40B20212022202320242025
3.89B
3.66B
(TEVA) Total Revenue
(KVUE) Total Revenue
Values in USD except per share items

TEVA vs. KVUE - Profitability Comparison

The chart below illustrates the profitability comparison between Teva Pharmaceutical Industries Limited and Kenvue Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.
Gross Margin
Operating Margin
Net Margin
Quarterly
Annual
45.0%50.0%55.0%60.0%20212022202320242025
48.2%
56.5%
(TEVA) Gross Margin
(KVUE) Gross Margin
TEVA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Teva Pharmaceutical Industries Limited reported a gross profit of 1.88B and revenue of 3.89B. Therefore, the gross margin over that period was 48.2%.

KVUE - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Kenvue Inc. reported a gross profit of 2.07B and revenue of 3.66B. Therefore, the gross margin over that period was 56.5%.

TEVA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Teva Pharmaceutical Industries Limited reported an operating income of 706.00M and revenue of 3.89B, resulting in an operating margin of 18.1%.

KVUE - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Kenvue Inc. reported an operating income of 483.00M and revenue of 3.66B, resulting in an operating margin of 13.2%.

TEVA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Teva Pharmaceutical Industries Limited reported a net income of 214.00M and revenue of 3.89B, resulting in a net margin of 5.5%.

KVUE - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Kenvue Inc. reported a net income of 293.00M and revenue of 3.66B, resulting in a net margin of 8.0%.